E

Emcure Pharmaceuticals Ltd
NSE:EMCURE

Watchlist Manager
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Watchlist
Price: 1 540.6 INR 1.24% Market Closed
Market Cap: 292B INR

Intrinsic Value

The intrinsic value of one EMCURE stock under the Base Case scenario is hidden INR. Compared to the current market price of 1 540.6 INR, Emcure Pharmaceuticals Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

EMCURE Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Emcure Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

EMCURE looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether EMCURE usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about EMCURE?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is EMCURE valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Emcure Pharmaceuticals Ltd.

Explain Valuation
Compare EMCURE to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EMCURE?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Emcure Pharmaceuticals Ltd

Balance Sheet Decomposition
Emcure Pharmaceuticals Ltd

Current Assets 45.6B
Cash & Short-Term Investments 2.4B
Receivables 22.9B
Other Current Assets 20.3B
Non-Current Assets 36.8B
Long-Term Investments 221.3m
PP&E 24.3B
Intangibles 9.5B
Other Non-Current Assets 2.8B
Current Liabilities 26.7B
Accounts Payable 14.8B
Accrued Liabilities 2B
Short-Term Debt 4.7B
Other Current Liabilities 5.1B
Non-Current Liabilities 11.2B
Long-Term Debt 4.5B
Other Non-Current Liabilities 6.7B
Efficiency

Free Cash Flow Analysis
Emcure Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Emcure Pharmaceuticals Ltd

Revenue
84.5B INR
Cost of Revenue
-33.7B INR
Gross Profit
50.8B INR
Operating Expenses
-39B INR
Operating Income
11.8B INR
Other Expenses
-3.9B INR
Net Income
7.9B INR
Fundamental Scores

EMCURE Profitability Score
Profitability Due Diligence

Emcure Pharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROE
Exceptional Gross Margin
Positive 3Y Average ROIC
Strong 3Y Average Gross Margin
hidden
Profitability
Score

Emcure Pharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

EMCURE Solvency Score
Solvency Due Diligence

Emcure Pharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
High Interest Coverage
Low D/E
Long-Term Solvency
hidden
Solvency
Score

Emcure Pharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EMCURE Price Targets Summary
Emcure Pharmaceuticals Ltd

Wall Street analysts forecast EMCURE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EMCURE is 1 696.77 INR with a low forecast of 1 565.5 INR and a high forecast of 1 837.5 INR.

Lowest
Price Target
1 565.5 INR
2% Upside
Average
Price Target
1 696.77 INR
10% Upside
Highest
Price Target
1 837.5 INR
19% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for EMCURE is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one EMCURE stock?

The intrinsic value of one EMCURE stock under the Base Case scenario is hidden INR.

Is EMCURE stock undervalued or overvalued?

Compared to the current market price of 1 540.6 INR, Emcure Pharmaceuticals Ltd is hidden .

Back to Top